Episode

Eukaryotes Draw Origins Challenge, Polygenic Scores Boost Steroid Side Effects Prediction, Immune Genes Drive Rare Neurodegeneration, Joint Breakthrough Regenerates Cartilage, and more...

Podcast
Science News Daily
Published
Jun 15, 2026
Duration seconds
689
Processing state
not_requested
Canonical source
https://share.transistor.fm/s/eec651a9
Audio
https://media.transistor.fm/eec651a9/052d9849.mp3
JSON
/v1/public/podcasts/science-news-daily-6698943/episodes/eukaryotes-draw-origins-challenge-polygenic-scores-boost-steroid-side-effects-prediction-immune-genes-drive-rare-neurodegeneration-joint-breakthrough-regenerates-cartilage-and-more
Markdown
/podcast/science-news-daily-6698943/eukaryotes-draw-origins-challenge-polygenic-scores-boost-steroid-side-effects-prediction-immune-genes-drive-rare-neurodegeneration-joint-breakthrough-regenerates-cartilage-and-more.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/science-news-daily-6698943/episodes/eukaryotes-draw-origins-challenge-polygenic-scores-boost-steroid-side-effects-prediction-immune-genes-drive-rare-neurodegeneration-joint-breakthrough-regenerates-cartilage-and-more/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/science-news-daily-6698943/eukaryotes-draw-origins-challenge-polygenic-scores-boost-steroid-side-effects-prediction-immune-genes-drive-rare-neurodegeneration-joint-breakthrough-regenerates-cartilage-and-more.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

(0:10): New Study Reveals Eukaryotes' Complex Multi-Source Origins, Challenging Single-Endosymbiosis Theory (2:49): Polygenic Risk Scores Enhance Prediction of Steroid Side Effects, Paving Way for Personalized Medicine (4:32): CD99L2 Gene Identified as Key Player in Rare Spastic Ataxia; Study Links Immune Genes to Neurodegeneration (6:23): Breakthrough in Joint Repair: Enzyme Blockade Regenerates Cartilage, Halts Osteoarthritis Progression (8:23): Legend Biotech Unveils Promising Clinical Data for LB2501 CAR‑T Therapy in B-Cell Non‑Hodgkin Lymphoma To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: Mirage News